Clarithromycin for improved clinical outcomes in community-acquired pneumonia: A subgroup analysis of the ACCESS trial.
Akinosoglou K, Leventogiannis K, Tasouli E, Kakavoulis N, Niotis G, Doulou S, Skorda L, Iliopoulou K, Papailiou A, Katsaounou P, Rapti V, Chrysos G, Seferlis T, Gerakari S, Dakou K, Papanikolaou IC, Milionis H, Kewitz S, Georgiadou S, Kontopoulou T, Tzavara V, Torres A, Niederman MS, Giamarellos-Bourboulis EJ.
Akinosoglou K, et al. Among authors: seferlis t.
Int J Antimicrob Agents. 2024 Dec 6;65(2):107406. doi: 10.1016/j.ijantimicag.2024.107406. Online ahead of print.
Int J Antimicrob Agents. 2024.
PMID: 39647798
Free article.